Assessment of telomerase as drug target in breast cancer
J Biosci
;
2020 May; : 1-11
Artículo
| IMSEAR
| ID: sea-214289
ABSTRACT
Telomerase is a specialized enzyme which maintains telomere length at the extreme end of the chromosome.Over 90% of all cases of cancer show high expression of telomerase while in normal cells, its expression isextremely low or undetectable. Detection of telomerase activity in a wide range of breast cancer makestelomerase an interesting target for diagnosis and therapy. In this review, we have aimed to describe telomeraseas a therapeutic and accurate diagnostic target in breast cancer. Telomerase performs many extracurricularactivities apart from maintaining telomere length; here, we have also tried to address its role in epithelialmesenchymal transition (EMT) of breast cancer progression.
Texto completo:
Disponible
Índice:
IMSEAR (Asia Sudoriental)
Revista:
J Biosci
Año:
2020
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS